Table 2

Effect of Empagliflozin on weight change and weight change per mean daily loop diuretic dose

EndpointDayAdjusteda mean (SE)Adjusteda mean difference (95% confidence interval), P-value
EmpagliflozinPlacebo
Body weight change from baseline (kg)15−3.20 (0.32)−1.23 (0.32)−1.97 (−2.86, −1.08), <0.0001
30−3.19 (0.36)−1.45 (0.36)−1.74 (−2.73, −0.74), 0.0007
90−2.36 (0.44)−0.83 (0.44)−1.53 (−2.75, −0.31), 0.0137
Body weight change from baseline per mean daily loop diuretic dose (kg/40 mg furosemide or equivalent)15−3.33 (0.53)−1.02 (0.52)−2.31 (−3.77, −0.85), 0.0020
30−3.80 (0.81)−1.01 (0.81)−2.79 (−5.03, −0.54), 0.0152
90−2.85 (1.04)0.33 (1.05)−3.18 (−6.08, −0.28), 0.0319
EndpointDayAdjusteda mean (SE)Adjusteda mean difference (95% confidence interval), P-value
EmpagliflozinPlacebo
Body weight change from baseline (kg)15−3.20 (0.32)−1.23 (0.32)−1.97 (−2.86, −1.08), <0.0001
30−3.19 (0.36)−1.45 (0.36)−1.74 (−2.73, −0.74), 0.0007
90−2.36 (0.44)−0.83 (0.44)−1.53 (−2.75, −0.31), 0.0137
Body weight change from baseline per mean daily loop diuretic dose (kg/40 mg furosemide or equivalent)15−3.33 (0.53)−1.02 (0.52)−2.31 (−3.77, −0.85), 0.0020
30−3.80 (0.81)−1.01 (0.81)−2.79 (−5.03, −0.54), 0.0152
90−2.85 (1.04)0.33 (1.05)−3.18 (−6.08, −0.28), 0.0319
a

Adjusted for HF status and baseline value by visit interaction.

Table 2

Effect of Empagliflozin on weight change and weight change per mean daily loop diuretic dose

EndpointDayAdjusteda mean (SE)Adjusteda mean difference (95% confidence interval), P-value
EmpagliflozinPlacebo
Body weight change from baseline (kg)15−3.20 (0.32)−1.23 (0.32)−1.97 (−2.86, −1.08), <0.0001
30−3.19 (0.36)−1.45 (0.36)−1.74 (−2.73, −0.74), 0.0007
90−2.36 (0.44)−0.83 (0.44)−1.53 (−2.75, −0.31), 0.0137
Body weight change from baseline per mean daily loop diuretic dose (kg/40 mg furosemide or equivalent)15−3.33 (0.53)−1.02 (0.52)−2.31 (−3.77, −0.85), 0.0020
30−3.80 (0.81)−1.01 (0.81)−2.79 (−5.03, −0.54), 0.0152
90−2.85 (1.04)0.33 (1.05)−3.18 (−6.08, −0.28), 0.0319
EndpointDayAdjusteda mean (SE)Adjusteda mean difference (95% confidence interval), P-value
EmpagliflozinPlacebo
Body weight change from baseline (kg)15−3.20 (0.32)−1.23 (0.32)−1.97 (−2.86, −1.08), <0.0001
30−3.19 (0.36)−1.45 (0.36)−1.74 (−2.73, −0.74), 0.0007
90−2.36 (0.44)−0.83 (0.44)−1.53 (−2.75, −0.31), 0.0137
Body weight change from baseline per mean daily loop diuretic dose (kg/40 mg furosemide or equivalent)15−3.33 (0.53)−1.02 (0.52)−2.31 (−3.77, −0.85), 0.0020
30−3.80 (0.81)−1.01 (0.81)−2.79 (−5.03, −0.54), 0.0152
90−2.85 (1.04)0.33 (1.05)−3.18 (−6.08, −0.28), 0.0319
a

Adjusted for HF status and baseline value by visit interaction.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close